In addition to the millions of lives claimed by COVID-19, another group of victims has emerged: the users and abusers of prescription and illicit drugs alike, who—as a potential result of decreased drug testing during the pandemic—have seen their overdose rates skyrocket.
In a presentation during the 2021 virtual annual meeting of the American Academy of Pain Medicine, Jeffrey Gudin, MD, a faculty member in the Department of Anesthesiology, Perioperative Medicine